Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
140 participants
INTERVENTIONAL
2025-03-25
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk
NCT06941311
Child STEPS for Youth Mental Health in Maine Sustainability
NCT03112304
Brief Suicide Intervention for Youth in Juvenile Detention Settings
NCT05225103
Preventing Youth Suicide in Primary Care: A Family Model
NCT00604097
Safer Still (Exploratory Project 3)
NCT06558409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Aim 1 of the research plan, the investigators will refine the STAY protocol and intervention plan based on the study team's preliminary development of the STAY model, protocol, and implementation plan. The STAY protocol includes a clinician manual (including clinician guide for each STAY component, step-by-step instructions, sample scripts, clinical vignettes) and assessment measures. The STAY implementation plan includes the STAY training, goals and objectives, responsibilities, and timelines. The investigators will employ user-centered design (UCD) methods guided by a Discover, Design, Build, and Test (DDBT) Development process to revise the STAY protocol and implementation plan to ensure STAY is aligned with the needs of deployment contexts and end users. A sample size of N=12 users (i.e., clinicians and clinical administrators) divided into three cohorts of four participants each will be used as per recommendations for user-centered design (UCD) testing for complex interventions. Aligned with best practices, sampling will balance both novice and more experienced users. Participants will interact with the STAY protocol and implementation plan prototypes and engage in usability tests, including cognitive walk-throughs and lab-based user testing. Participants will also compete the 10-item Intervention Usability Scale. Iterative data analysis and prototyping between each cohort will be used to rapidly refine the STAY protocol and implementation plan to optimize usability. Then, the STAY Observational Coding System (SOCS) will be developed to assess its feasibility and scalability for future trials, as well as a 10-item STAY Knowledge, Skills and Attitudes (KSAT) Measure to tap core knowledge domains and implementation mechanisms to be assessed in the Aim 2 trial. At the end of Aim 1, the study team will have refined a STAY protocol and implementation plan. The investigators will also have an observational coding system to assess STAY fidelity and a brief, pragmatic measure to assess knowledge, attitudes and practices of clinicians trained in STAY.
In Aim 2 of the research plan, the investigators will conduct a pilot effectiveness-implementation Hybrid Type 2 trial of STAY vs MBC As Usual. Using a randomized design, 20 clinicians at three public mental health sites will be stratified by site and randomly assigned to STAY (intervention condition) or to MBC As Usual (active control condition). Clinicians randomized to STAY will receive the STAY protocol, and MBC As Usual clinicians will receive standard MBC educational materials used in the study team's other MBC studies. Clinicians in both conditions will attend a one-day training and monthly, 1-hour, post-training consultation calls for 6 months. Clinicians in both conditions will be asked to implement MBC with REM youth and their families who meet eligibility criteria and facilitate study referrals. All clinicians will complete measures at baseline (pre-training) and post-training and post-implementation (6-month post-training follow-up). Half of the clinicians in each condition will be randomly selected to participate in the SOCS. Youth/caregiver dyads will be recruited on a rolling basis due to enrollment patterns at the clinical sites, which is why the investigators are planning 20 months of data collection to achieve 4-month follow-up measures from all youth. Youth and caregivers will complete measures at baseline (within 30 days of their first contact with the site), 2-months (8 weeks) and 4-months (16 weeks) following the baseline measure. Youth measures capture implementation outcomes (e.g., clinicians' cultural humility and cultural comfort), engagement mechanisms (e.g., treatment relevance and acceptability, therapeutic alliance), service outcomes (e.g., attitudinal engagement), and youth symptom outcomes (e.g., depression symptoms, suicidal ideation and behavior). Caregiver measures capture implementation outcomes (e.g., clinicians' cultural comfort), engagement mechanisms (e.g., treatment relevance and acceptability, therapeutic alliance), and service outcomes (e.g., attitudinal engagement). Youth and caregivers will also be asked to consent to secondary data collection by the study team to obtain medical records information for their attendance, discharge reason and fidelity of MBC. Clinician measures capture implementation outcomes (e.g., feasibility, acceptability, appropriateness).
The investigators will assess STAY implementation outcomes of fidelity, feasibility, acceptability, and appropriateness (primary outcomes). Further, the investigators will explore whether STAY, as compared to MBC As Usual, will result in (secondary outcomes): (1) Greater therapeutic alliance and treatment relevance and acceptability (engagement mechanisms); (2) Greater session attendance, attitudinal engagement and treatment completion (service outcomes); and (3) Greater reduction in youth depressive symptoms, suicidal ideation and behavior (treatment outcomes).
Appropriateness of Methods Follow up intervals are informed by typical treatment length and retention measures in prior research. Sample size was determined based on the resources and time frame constraints of 3 years; participating clinicians and families will be recruited in year 1, quarter 4 to finish all data collection in year 2. Also, individual clinician patterns in MBC administration and feedback can feasibly be examined with this small sample size, as has been useful in other implementation pilot studies.
Knowledge gained from this pilot will be used to refine the research strategy for a fully powered, subsequent R01 with optimal procedures. Piloting STAY with procedures that would be exactly mirrored in a future, multi-site R01 provides numerous learning opportunities about the feasibility and parameters of measures, study recruitment and data collection procedures (e.g., collecting youth- and caregiver-reported data over the phone), clinician engagement in consultation calls, record review procedures to track fidelity, missing data patterns, and range and pattern of session attendance for both the STAY and MBC As Usual groups. Also, site variation in this trial is expected to provide information about how different sites handle STAY implementation, which the investigators can further investigate as site-level variation in a fully-powered R01 trial. Outcomes of this trial could inform potential additions to the R01 design, such as 1) enhancements to STAY to more comprehensively address logistical barriers, 2) testing STAY among REM adolescents with conditions other than depression, and/or 3) a fully-powered Type 2 Hybrid trial to detect clinician effects, moderators, and effectiveness outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Strategic Treatment Assessment for Youth (STAY)
Clinicians assigned to the STAY condition will receive training and ongoing consultation in the STAY protocol and implementation plan. STAY is a culturally-modified version of measurement-based care (MBC) for racial and ethnic minoritized adolescents. Clinicians in this condition will receive training materials and consultation on standard MBC practices using the PHQ-9-A for depression plus cultural competence training, the "Introduce" component to assess and address treatment expectations at the start of care, and individualized goal and alliance progress measures.
Strategic Treatment Assessment for Youth (STAY)
Culturally tailored measurement based care
Measurement-Based Care (MBC) As Usual
Clinicians assigned to the active comparison condition will receive standard MBC training and ongoing consultation that is routinely used and evaluated by the research team with child and adolescent mental health clinicians. MBC As Usual training materials will be customized to focus on collection and use of the PHQ-A with adolescents and their caregivers using a feedback system. MBC As Usual clinicians will be offered the opportunity to be trained in STAY at the conclusion of data collection
Measurement Based Care As Usual
Measurement based care as usual
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strategic Treatment Assessment for Youth (STAY)
Culturally tailored measurement based care
Measurement Based Care As Usual
Measurement based care as usual
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Identify as a racial or ethnic minoritized (i.e., Black or African American; American Indian or Alaska Native; Asian American, Native Hawaiian or Other Pacific Islander; Hispanic or Latinx) youth
* Have at least moderate depression symptoms based on moderate range of a validated depression assessment collected at intake by the participating agency such as the Center for Epidemiological Studies Depression Scale for Children (CES-DC) or Hamilton Depression Index with or without Parent- or adolescent- reported or healthcare provider- documented thoughts and/or behaviors related to self-harm or suicide in the three (3) months prior to first contact with participating agency
* Assigned or triaged to work with one of the clinician participants included in the study (below)
* Made first contact (e.g., initial phone call, attended intake appointment) with a participating agency less than or equal to one (1) month prior to the recruitment date (but ideally within (1) week of intake appointment)
* English- or Spanish-speaking
* Legal parent or guardian available to provide informed consent
* Able to provide informed assent
* Legal guardian of one of the adolescent client participants included in the study (above)
* English-speaking
* Able to provide informed consent
* Provides community-based mental health treatment to youth
* Holds a professional license or certification in their state to provide mental health treatment OR are supervised by a clinician with professional license or certification in their state to provide mental health treatment
* Are a clinician identified for recruitment because they are part of a participating mental health clinic/site
* Age 18 or older
* English- or Spanish-speaking
* Able to provide informed consent
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Teachers College, Columbia University
OTHER
National Institute of Mental Health (NIMH)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Connors, PhD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ingoldsby EM. Review of Interventions to Improve Family Engagement and Retention in Parent and Child Mental Health Programs. J Child Fam Stud. 2010 Oct 1;19(5):629-645. doi: 10.1007/s10826-009-9350-2.
Lyon AR, Dopp AR, Brewer SK, Kientz JA, Munson SA. Designing the Future of Children's Mental Health Services. Adm Policy Ment Health. 2020 Sep;47(5):735-751. doi: 10.1007/s10488-020-01038-x.
Lyon AR, Koerner K. User-Centered Design for Psychosocial Intervention Development and Implementation. Clin Psychol (New York). 2016 Jun;23(2):180-200. doi: 10.1111/cpsp.12154. Epub 2016 Jun 17.
Lyon AR, Munson SA, Renn BN, Atkins DC, Pullmann MD, Friedman E, Arean PA. Use of Human-Centered Design to Improve Implementation of Evidence-Based Psychotherapies in Low-Resource Communities: Protocol for Studies Applying a Framework to Assess Usability . JMIR Res Protoc. 2019 Oct 9;8(10):e14990. doi: 10.2196/14990.
Turner AM, Reeder B, Ramey J. Scenarios, personas and user stories: user-centered evidence-based design representations of communicable disease investigations. J Biomed Inform. 2013 Aug;46(4):575-84. doi: 10.1016/j.jbi.2013.04.006. Epub 2013 Apr 22.
Yeager DS, Romero C, Paunesku D, Hulleman CS, Schneider B, Hinojosa C, Lee HY, O'Brien J, Flint K, Roberts A, Trott J, Greene D, Walton GM, Dweck CS. Using Design Thinking to Improve Psychological Interventions: The Case of the Growth Mindset During the Transition to High School. J Educ Psychol. 2016 Apr;108(3):374-391. doi: 10.1037/edu0000098.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
Bauer AM, Baldwin SA, Anguera JA, Arean PA, Atkins DC. Comparing Approaches to Mobile Depression Assessment for Measurement-Based Care: Prospective Study. J Med Internet Res. 2018 Jun 19;20(6):e10001. doi: 10.2196/10001.
Fortney JC, Unutzer J, Wrenn G, Pyne JM, Smith GR, Schoenbaum M, Harbin HT. A Tipping Point for Measurement-Based Care. Focus (Am Psychiatr Publ). 2018 Jul;16(3):341-350. doi: 10.1176/appi.focus.16303. Epub 2018 Jul 16.
Guo T, Xiang YT, Xiao L, Hu CQ, Chiu HF, Ungvari GS, Correll CU, Lai KY, Feng L, Geng Y, Feng Y, Wang G. Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters. Am J Psychiatry. 2015 Oct;172(10):1004-13. doi: 10.1176/appi.ajp.2015.14050652. Epub 2015 Aug 28.
Glazer K, Rootes-Murdy K, Van Wert M, Mondimore F, Zandi P. The utility of PHQ-9 and CGI-S in measurement-based care for predicting suicidal ideation and behaviors. J Affect Disord. 2020 Apr 1;266:766-771. doi: 10.1016/j.jad.2018.05.054. Epub 2018 Jun 15.
Richardson TM, He H, Podgorski C, Tu X, Conwell Y. Screening depression aging services clients. Am J Geriatr Psychiatry. 2010 Dec;18(12):1116-23. doi: 10.1097/JGP.0b013e3181dd1c26.
Gipson PY, Agarwala P, Opperman KJ, Horwitz A, King CA. Columbia-suicide severity rating scale: predictive validity with adolescent psychiatric emergency patients. Pediatr Emerg Care. 2015 Feb;31(2):88-94. doi: 10.1097/PEC.0000000000000225.
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.
Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. doi: 10.1111/j.1475-6773.2004.00269.x.
Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30. doi: 10.1111/j.1475-6773.2005.00438.x.
Miller GE, Prinz RJ. Engagement of families in treatment for childhood conduct problems. Behavior Therapy. 2003; 34(4): 517-534.
Kazdin AE. Acceptability of alternative treatments for deviant child behavior. J Appl Behav Anal. 1980 Summer;13(2):259-73. doi: 10.1901/jaba.1980.13-259.
Spirrison, CL, Noland, KA, Savoie, LB. Factor structure of the Treatment Evaluation Inventory: Implications for measurement of treatment acceptability. J Psychopathol Behav Assess. 1992; 14: 65-79.
Carter, SL. Review of Recent Treatment Acceptability Research. Education and Training in Developmental Disabilities. 2007; 42(3): 301-316.
Hatcher, RL, Gillaspy, JA. Development and validation of a revised short version of the working alliance inventory. Psychotherapy Research. 2006; 16(1): 12-25.
Munder T, Wilmers F, Leonhart R, Linster HW, Barth J. Working Alliance Inventory-Short Revised (WAI-SR): psychometric properties in outpatients and inpatients. Clin Psychol Psychother. 2010 May-Jun;17(3):231-9. doi: 10.1002/cpp.658.
Ebesutani C, Chorpita BF, Higa-McMillan CK, Nakamura BJ, Regan J, Lynch RE. A psychometric analysis of the Revised Child Anxiety and Depression Scales--parent version in a school sample. J Abnorm Child Psychol. 2011 Feb;39(2):173-85. doi: 10.1007/s10802-010-9460-8.
Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.
Stumpf RE, Higa-McMillan CK, Chorpita BF. Implementation of evidence-based services for youth: assessing provider knowledge. Behav Modif. 2009 Jan;33(1):48-65. doi: 10.1177/0145445508322625. Epub 2008 Aug 22.
Lawson GM, Moore TM, Okamura KH, Becker-Haimes EM, Beidas RS. Knowledge of Evidence-Based Services Questionnaire: Development and Validation of a Short Form. Adm Policy Ment Health. 2020 Jul;47(4):581-596. doi: 10.1007/s10488-020-01020-7.
Jensen-Doss A, Haimes EMB, Smith AM, Lyon AR, Lewis CC, Stanick CF, Hawley KM. Monitoring Treatment Progress and Providing Feedback is Viewed Favorably but Rarely Used in Practice. Adm Policy Ment Health. 2018 Jan;45(1):48-61. doi: 10.1007/s10488-016-0763-0.
Lyon AR, Pullmann MD, Whitaker K, Ludwig K, Wasse JK, McCauley E. A Digital Feedback System to Support Implementation of Measurement-Based Care by School-Based Mental Health Clinicians. J Clin Child Adolesc Psychol. 2019;48(sup1):S168-S179. doi: 10.1080/15374416.2017.1280808. Epub 2017 Mar 2.
Connors EH, Douglas S, Jensen-Doss A, Landes SJ, Lewis CC, McLeod BD, Stanick C, Lyon AR. What Gets Measured Gets Done: How Mental Health Agencies can Leverage Measurement-Based Care for Better Patient Care, Clinician Supports, and Organizational Goals. Adm Policy Ment Health. 2021 Mar;48(2):250-265. doi: 10.1007/s10488-020-01063-w.
Hook JN, Davis DE, Owen J, Worthington EL, Utsey SO. Cultural humility: measuring openness to culturally diverse clients. J Couns Psychol. 2013 Jul;60(3):353-366. doi: 10.1037/a0032595. Epub 2013 May 6.
Ponterotto, JG, Potere, JC. The Multicultural Counseling Knowledge and Awareness Scale (MCKAS): Validity, Reliability, and User Guidelines. In D. B. Pope-Davis, H. L. K. Coleman, W. M. Liu, & R. L. Toporek (Eds.), Handbook of multicultural competencies: In counseling & psychology. Sage Publications, Inc. 2003: 137-153.
Constantine, MG, Ladany, N. Self-report multicultural counseling competence scales: Their relation to social desirability attitudes and multicultural case conceptualization ability. Journal of Counseling Psychology. 2000; 47(2): 155-164.
Ehrhart MG, Aarons GA, Farahnak LR. Assessing the organizational context for EBP implementation: the development and validity testing of the Implementation Climate Scale (ICS). Implement Sci. 2014 Oct 23;9:157. doi: 10.1186/s13012-014-0157-1.
Dew-Reeves SE, Athay MM. Validation and use of the youth and caregiver Treatment Outcome Expectations Scale (TOES) to assess the relationships between expectations, pretreatment characteristics, and outcomes. Adm Policy Ment Health. 2012 Mar;39(1-2):90-103. doi: 10.1007/s10488-012-0406-z.
Riemer M, Athay MM, Bickman L, Breda C, Kelley SD, Vides de Andrade AR. The Peabody Treatment Progress Battery: history and methods for developing a comprehensive measurement battery for youth mental health. Adm Policy Ment Health. 2012 Mar;39(1-2):3-12. doi: 10.1007/s10488-012-0404-1.
Perez-Rojas AE, Bartholomew TT, Lockard AJ, Gonzalez JM. Development and initial validation of the Therapist Cultural Comfort Scale. J Couns Psychol. 2019 Oct;66(5):534-549. doi: 10.1037/cou0000344. Epub 2019 Apr 18.
Bartholomew TT, Perez-Rojas AE, Lockard AJ, Joy EE, Robbins KA, Kang E, Maldonado-Aguiniga S. Therapists' cultural comfort and clients' distress: An initial exploration. Psychotherapy (Chic). 2021 Jun;58(2):275-281. doi: 10.1037/pst0000331. Epub 2020 Nov 19.
Lyon AR, Pullmann MD, Jacobson J, Osterhage K, Achkar MA, Renn BN, Munson SA, Arean PA. Assessing the Usability of Complex Psychosocial Interventions: The Intervention Usability Scale. Implement Res Pract. 2021 Jan-Dec;2:2633489520987828. doi: 10.1177/2633489520987828. Epub 2021 Feb 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-063
Identifier Type: OTHER
Identifier Source: secondary_id
2000036704
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.